Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Requires little to no down-time after each treatment every time
it balances the blood sugar
Phase 2 trial: the study that started it all The Phase 2 trial, published in the New England Journal of Medicine under the title "Triple Hormone Receptor Agonist Retatrutide for Obesity," is the foundation upon which the entire Phase 3 program was built
The full effects build as you titrate to your target maintenance dose, with maximum efficacy reached 4 to 8 weeks after achieving your final dose
US$ 25.61
US$ 23.81
US$ 28.16
US$ 22.87
US$ 28.69
US$ 24.22
US$ 23.41
US$ 28.89
US$ 29.35
US$ 28.37
